
- •Overview of Chromatin / Epigenetics
- •Protein Acetylation Signaling Pathway
- •Histone Lysine Methylation Pathway
- •Van Rechem c, Whetstine jr (2014) Examining the impact of gene variants on histone lysine methylation. Biochim. Biophys. Acta 1839(12), 1463–76.
- •Overview of map Kinase Signaling
- •Mapk/Erk in Growth and Differentiation Signaling Pathway
- •Sapk/jnk Signaling Pathway
- •Verma g, Datta m (2012) The critical role of jnk in the er-mitochondrial crosstalk during apoptotic cell death. J. Cell. Physiol. 227(5), 1791–5.
- •Signaling Pathways Activating p38 map Kinase
- •Overview of Apoptosis
- •Regulation of Apoptosis: Overview
- •Death Receptor Signaling Pathway
- •Van Herreweghe f, Festjens n, Declercq w, Vandenabeele p (2010) Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell. Mol. Life Sci. 67(10), 1567–79.
- •Overview of Autophagy Resources
- •Autophagy Signaling Pathway
- •Translational Control Overview
- •Translational Control / Regulation of eIf2
- •Overview of Calcium, cAmp, and Lipid Signaling
- •Protein Kinase c Signaling
- •Phospholipase Signaling
- •Overview of Cell Cycle, Checkpoint Control and dna Damage
- •Van den Heuvel s, Dyson nj (2008) Conserved functions of the pRb and e2f families. Nat. Rev. Mol. Cell Biol. 9(9), 713–24.
- •Cell Cycle g1/s Checkpoint Signaling Pathway
- •Van den Heuvel s, Dyson nj (2008) Conserved functions of the pRb and e2f families. Nat. Rev. Mol. Cell Biol. 9(9), 713–24.
- •Cell Cycle g2/m dna Damage Signaling Pathway
- •Overview of Cellular Metabolism
- •Ampk Signaling Pathway
- •Warburg Effect Signaling Pathway
- •Vander Heiden mg, Cantley lc, Thompson cb (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930), 1029–33.
- •Overview of Stem Cell Markers, Development and Differentiation
- •Hippo Signaling Pathway
- •Notch Signaling Pathway
- •Hedgehog Signaling Pathway
- •Overview of Immunology and Inflammation
- •Jak/Stat Signaling Pathway
- •Vainchenker w, Constantinescu sn (2013) jak/stat signaling in hematological malignancies. Oncogene 32(21), 2601–13.
- •Toll-like Receptors (tlRs) Pathway
- •B Cell Receptor Signaling Pathway
- •T Cell Receptor Signaling Pathway
- •Overview of Tyrosine Kinase Signaling
- •ErbB / her Signaling Pathway
- •Angiogenesis Overview
- •Angiogenesis Signaling Pathway
- •Van Hinsbergh vw, Koolwijk p (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc. Res. 78(2), 203–12.
- •Adherens Junction Pathway
- •Overview of Neuroscience
- •Dopamine Signaling in Parkinson's Disease Pathway
- •Imai y, Lu b (2011) Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder. Curr. Opin. Neurobiol. 21(6), 935–41.
- •Van der Vaart b, Akhmanova a, Straube a (2009) Regulation of microtubule dynamic instability. Biochem. Soc. Trans. 37(Pt 5), 1007–13.
- •Regulation of Actin Dynamics Signaling Pathway
- •Overview of Nuclear Receptors
- •Nuclear Receptor Signaling
- •Overview of Ubiquitin and Ubiquitin-Like Proteins
- •Ubiquitin / Proteasome Pathway
- •Protein Folding
Histone Lysine Methylation Pathway
Pathway Description:
The nucleosome is the primary building block of chromatin containing a histone octamer composed of two sets of H3-H4 and H2A-H2B dimers. Originally thought to function as a static scaffold for DNA packaging, histones have more recently been shown to be dynamic proteins, undergoing multiple types of post-translational modifications and impacting numerous nuclear functions. Lysine methylation is one such modification and is a major determinant for genome organization and the formation of active and inactive regions of the genome. Lysines can have three different methylation states (mono-, di-, and tri-) that are associated with different nuclear features and transcriptional states. In order to establish these methylation states, cells have enzymes that both add (lysine methyltransferases- KMTs) and remove (lysine demethylases- KDMs) different degrees of methylation from specific lysines within the histones. To date, all but one histone lysine methyltransferase (DOT1L/KMT4) has a conserved catalytic SET domain that was originally identified in the Drosophila Su[var]3-9, Enhancer of zeste, and Trithorax proteins. In the case of the histone lysine demethylases, there are two different classes: the FAD-dependent amine oxidases and the JmjC-containing enzymes. Both KMTs and KDMs have specificity for specific lysine residues and degrees of methylation within the histone tails. Therefore, all KMTs and KDMs are not the same in their biological functions or roles in transcriptional output.
Lysine methylation has been implicated in both transcriptional activation (H3K4, K36, K79) and silencing (H3K9, K27, H4K20). The degree of methylation is associated with different outcomes. For example, H4K20 monomethyation (H4K20me1) is observed in the bodies of active genes, while H4K20 trimethylation (H4K20me3) is affiliated with gene repression and compacted genomic regions. Gene regulation is also affected by the location of the methylated lysine residue with respect to the DNA sequence. For example, H3K9me3 at promoters is associated with gene repression, while some induced genes have H3K9me3 in the gene body. Since this modification is uncharged and chemically inert, the impact these modifications have is through recognition by other proteins with binding motifs. Lysine methylation coordinates the recruitment of chromatin modifying enzymes. Chromodomains (e.g., found in HP1, PRC1), PHD fingers (e.g., found in BPTF, ING2, SMCX/KDM5C), Tudor domains (e.g., found in 53BP1 and JMJD2A/KDM4A), PWWP domains (e.g., found in ZMYND11) and WD-40 domains (e.g., found in WDR5) are among a growing list of methyl lysine binding modules found in histone acetyltransferases, deacetylases, methylases, demethylases and ATP-dependent chromatin remodeling enzymes. Lysine methylation provides a binding surface for these enzymes, which then regulate chromatin condensation and nucleosome mobility, active and inactive transcription as well as DNA repair and replication. In addition, lysine methylation can block binding of proteins that interact with unmethylated histones or directly inhibit catalysis of other regulatory modifications on neighboring residues.
Histone methylation is crucial for proper programming of the genome during development and misregulation of the methylation machinery can lead to diseased states such as cancer. In fact, cancer genome analyses have uncovered lysine mutations in H3K27 and H3K36. These sites are enriched in subsets of cancer. Therefore, an entirely new therapeutic and biomarker space is emerging with the discovery of these enzymes, the impact modifications have on the genome and disease associated mutations.
Selected Reviews:
Black JC, Van Rechem C, Whetstine JR (2012) Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol. Cell 48(4), 491–507.
Greer EL, Shi Y (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13(5), 343–57.
Herz HM, Garruss A, Shilatifard A (2013) SET for life: biochemical activities and biological functions of SET domain-containing proteins. Trends Biochem. Sci. 38(12), 621–39.
Kooistra SM, Helin K (2012) Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 13(5), 297–311.
Tee WW, Reinberg D (2014) Chromatin features and the epigenetic regulation of pluripotency states in ESCs. Development 141(12), 2376–90.